ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Normal Routines Dramatically Altered In Days Since Sept. 11 Terrorist Attacks.

September 21, 2001

OMB Caused The Problem But Did Not Order Transfer Of $20 Million From Centers Program to Grants Poll

April 29, 1983

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002

AIDS Drug Discovery Groups RFA Draws 20 Applications

May 9, 1986

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976